Provided by Tiger Trade Technology Pte. Ltd.

Jaguar Animal Health

4.41
-0.5860-11.72%
Volume:433.89K
Turnover:1.98M
Market Cap:22.81M
PE:0.00
High:4.94
Open:4.82
Low:4.37
Close:5.00
52wk High:1,152.61
52wk Low:2.35
Shares:5.17M
Float Shares:436.90K
Volume Ratio:0.08
T/O Rate:99.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2,338.1604
EPS(LYR):-12,059.1987
ROE:-548.83%
ROA:-38.04%
PB:3.45
PE(LYR):0.00

Loading ...

Jaguar says first patient from pediatric MVID entered active treatment

TIPRANKS
·
May 19

Jaguar Health extends pivotal MVID crofelemer trial into active-treatment phase

Reuters
·
May 19

Jaguar Health delays quarterly report filing after subsequent event transaction review

Reuters
·
May 19

Jaguar Health wins Nasdaq extension to regain $1 bid price compliance by May 18

Reuters
·
May 08

Jaguar Health discusses FDA breakthrough pathway for crofelemer in pediatric MVID trial

Reuters
·
May 06

Jaguar Animal Health Faces New Nasdaq Compliance Deficiency

TIPRANKS
·
May 04

Jaguar Health risks Nasdaq delisting after reverse split cuts public float below 500,000 shares

Reuters
·
May 04

Jaguar Animal Health trading halted, news pending

TIPRANKS
·
Apr 30

Jaguar Health announces results from trial of crofelemer

TIPRANKS
·
Apr 29

Jaguar Health says crofelemer trial meets primary endpoint in dogs with chemotherapy-induced diarrhea

Reuters
·
Apr 29

Jaguar Health granted extension to demonstrate compliance with Nasdaq bid rule

TIPRANKS
·
Apr 27

Jaguar Health executes 1-for-35 reverse stock split effective April 30

Reuters
·
Apr 27

Jaguar Health reports acceptance of abstracts on crofelemer for ESPGHAN meeting

TIPRANKS
·
Apr 24

Jaguar Health says two late-breaking pediatric intestinal failure crofelemer abstracts accepted at ESPGHAN

Reuters
·
Apr 24

Jaguar Health plans AI platforms to advance crofelemer clinical development for intestinal failure

Reuters
·
Apr 13

Jaguar Health hosts investor webcast on Q4 2025 financials and company updates

Reuters
·
Apr 10

Jaguar Animal Health Regains Nasdaq Compliance Through Capital Infusions

TIPRANKS
·
Apr 10